[1]	This number of shares excludes up to 375,000 Class B ordinary shares subject to surrender if the over-allotment option is not exercised in full or in part by the underwriter. As a result of the full exercise of the underwriter's over-allotment option on February 6, 2026, the 375,000 Class B ordinary shares are no longer subject to surrender (See Note 7).
[2]	This number of shares has been retroactively adjusted to reflect the recapitalization of the Company in the form of the cancellation of 7,187,500 Class B ordinary shares and 4,312,500 Class B ordinary shares on August 25, 2025 and December 19, 2025, respectively (See Note 7).

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ 1,308,723	$ (998)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
General and administrative expenses paid by related party	129,449
Interest income on investments held in the Trust Account	(1,603,109)
Changes in operating assets and liabilities:
Deferred offering costs	138,857	(162)
Prepaid expenses	166,535	998
Other assets	(78,312)
Accrued expenses	(44,447)	162
Net cash provided by operating activities	17,696
Cash flows from investing activities:
Purchase of available-for-sale debt securities held in Trust Account	(114,999,904)
Net cash provided by (used in) investing activities	(114,999,904)
Cash flows from financing activities:
Proceeds received from initial public offering	115,000,000
Proceeds received from private placement	3,000,000
Offering costs paid	(2,312,350)
Deferred offering costs paid by related party	(210,014)
Proceeds from Note payable – related party	125,795
Payment on Note payable – related party	(124,732)
Payment on Payable to related party	(471,491)
Net cash provided by financing activities	115,007,208
Net change in Cash	25,000
Cash – beginning of the period
Cash – end of the period	25,000
Supplemental disclosure of non-cash activities:
Deferred offering costs included in Accrued expenses		$ 162

Condensed Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash	$ 25,000
Prepaid expenses	175,507
Total Current Assets	200,507
Available-for-sale debt securities held in Trust Account, at fair value	116,606,482
Deferred offering costs		138,857
Other assets	78,312
Total Assets	116,885,301	138,857
Current Liabilities:
Accrued expenses	72,267	116,714
Notes payable – related party	85,768	84,705
Total Liabilities	158,035	201,419
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 11,500,000 and 0 shares issued and outstanding at redemption value of $10.14 and $0 per share as of June 30, 2026 and December 31, 2025, respectively	116,606,578
Shareholders’ Equity (Deficit):
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of both June 30, 2026 and December 31, 2025
Additional paid-in capital		24,712
Retained earnings (Accumulated deficit)	116,901	(87,562)
Accumulated other comprehensive income	3,469
Total Shareholders’ Equity (Deficit)	120,688	(62,562)
Total Liabilities, Commitments and Contingencies and Shareholders’ Equity (Deficit)	116,885,301	138,857
Class A Ordinary Shares
Shareholders’ Equity (Deficit):
Ordinary shares, value	30
Class B Ordinary Shares
Shareholders’ Equity (Deficit):
Ordinary shares, value	$ 288	$ 288